PRTN3 and rheumatoid arthritis: Painstaking research revealed that the RA patients possessing the shared epitope were very likely to have a more severe form of the disease and possess anti-citrullinated protein antibodies (ACPA) targeting citrullinated components of self (e.g. vimentin, aggrecan and others) [53,54].